You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRAF fusion

Showing 1 - 25 of 1,985
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Low Grade Glioma (LGG) of Brain With BRAF Aberration, High Grade Glioma (HGG) of the Brain With BRAF Aberration, Low Grade

Recruiting
  • Low Grade Glioma (LGG) of Brain With BRAF Aberration
  • +2 more
  • Phoenix, Arizona
  • +12 more
Apr 7, 2022

Non Small Cell Lung Cancer, Ovarian Cancer, RET Gene Mutation Trial in New York (RXDX-105)

Completed
  • Non Small Cell Lung Cancer
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center 1275 York Avenue
Sep 30, 2020

Low-grade Glioma, Plexiform Neurofibroma, CNS Glioma Trial in Canada (Trametinib)

Active, not recruiting
  • Low-grade Glioma
  • +2 more
  • Calgary, Alberta, Canada
  • +6 more
Oct 25, 2022

Cancer, Cancer Metastatic, NTRK Gene Fusion Overexpression Trial in Worldwide (Data collection and quality of life

Recruiting
  • Cancer
  • +15 more
  • Data collection and quality of life questionnaire
  • Graz, Austria
  • +40 more
Jul 27, 2021

ALK Fusion Protein Expression, BRAF wt Allele, Invasive Skin Melanoma Trial in San Francisco (Capmatinib, Ceritinib,

Terminated
Has Results
  • ALK Fusion Protein Expression
  • +14 more
  • San Francisco, California
    University of California, San Francisco
Jan 14, 2020

Low-grade Glioma, Advanced Solid Tumor Trial in Worldwide (DAY101)

Recruiting
  • Low-grade Glioma
  • Advanced Solid Tumor
  • San Francisco, California
  • +35 more
May 25, 2022

EGFR-mutant NSCLC Trial in Worldwide (EGF816, trametinib, ribociclib)

Active, not recruiting
  • EGFR-mutant Non-small Cell Lung Cancer
  • Toronto, Ontario, Canada
  • +10 more
Dec 5, 2022

Advanced Solid Tumor Trial in Australia, United States (Mirdametinib, BGB-3245)

Recruiting
  • Advanced Solid Tumor
  • La Jolla, California
  • +5 more
Jan 26, 2023

Low-Grade Gliomas, Malignant Tumors, Brain, Soft Tissue Tumors Trial in United States (MEK162)

Active, not recruiting
  • Low-Grade Gliomas
  • +2 more
  • Birmingham, Alabama
  • +14 more
Jan 25, 2023

Solid Tumor, B-Raf Mutation-Related Tumors Trial in Australia, United States (BGB-3245)

Recruiting
  • Solid Tumor
  • B-Raf Mutation-Related Tumors
  • Boston, Massachusetts
  • +4 more
Oct 25, 2022

Efficacy of Immunotherapy With Rare Mutations in Non-small Cell

Recruiting
  • Non Small Cell Lung Cancer
  • immunity therapy
  • Changsha, Hunan, China
  • +1 more
Feb 28, 2022

Oxidative Stress and Mitochondrial TERT in Papillary Thyroid

Recruiting
  • Papillary Thyroid Cancer
    • Milan, Italy
      Istituto Auxologico Italiano
    Mar 2, 2023

    Advanced Solid Tumor Trial in Changsha (IBI363)

    Not yet recruiting
    • Advanced Solid Tumor
    • Changsha, Hunan, China
      Yongchang Zhang
    Oct 12, 2023

    Solid Tumors Trial in Worldwide (Entrectinib, Alectinib, Atezolizumab)

    Recruiting
    • Solid Tumors
    • Daphne, Alabama
    • +156 more
    Jan 13, 2023

    Advanced Melanoma Trial (Tebentafusp, Tebentafusp with Pembrolizumab, Investigators Choice)

    Not yet recruiting
    • Advanced Melanoma
    • (no location specified)
    Sep 19, 2022

    China With Non-Small-Cell Lung Cancer That is Unable to be

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
      • (no location specified)
      May 16, 2023

      Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

      Recruiting
      • Advanced Malignant Solid Neoplasm
      • +44 more
      • Biopsy
      • +23 more
      • Birmingham, Alabama
      • +166 more
      Feb 2, 2023

      Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

      Recruiting
      • Lymphoma, Non-Hodgkin
      • +2 more
      • Birmingham, Alabama
      • +125 more
      Nov 21, 2022

      Rare Tumor, Refractory Tumor Trial in Shanghai (Gefitinib, Erlotinib, Afatinib)

      Recruiting
      • Rare Tumor
      • Refractory Tumor
      • Shanghai, Shanghai, China
        Shanghai Changzheng Hospital
      Feb 16, 2022

      Colon Adenocarcinoma, High-Frequency Microsatellite Instability, Metastatic Malignant Solid Tumor Trial in Houston

      Active, not recruiting
      • Colon Adenocarcinoma
      • +10 more
      • Anti-PD-L1/TGFbetaRII Fusion Protein M7824
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 12, 2022

      Advanced / Metastic Solid Tumors, Glioblastoma, Chronic Leukemia Lymphocytic Trial in Bron, Lyon (Blood and tumor samples)

      Recruiting
      • Advanced / Metastic Solid Tumors
      • +2 more
      • Blood and tumor samples
      • Bron, France
      • +1 more
      Jun 30, 2022

      Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

      Recruiting
      • Advanced Malignant Solid Neoplasm
      • +49 more
      • Birmingham, Alabama
      • +1429 more
      Aug 17, 2022

      Cancer Trial (Dabrafenib, Trametinib)

      Not yet recruiting
      • Cancer
      • (no location specified)
      May 25, 2023

      Clinical Utility of Oncomine Precision Assay Within Exactis

      Recruiting
      • NSCLC
        • Moncton, New Brunswick, Canada
        • +6 more
        Dec 9, 2022

        PLAsma Genomic Testing in Advanced Non-Small Cell Lung Cancer:

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • ctDNA liquid biopsy - Roche Avenio Assay
        • (no location specified)
        Sep 14, 2022